Related references
Note: Only part of the references are listed.Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
S. K. Kumar et al.
LEUKEMIA (2014)
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Camille Abboud et al.
BLOOD (2013)
Quality of Life in Long-Term Breast Cancer Survivors
Tina Hsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies
Darius N. Lakdawalla et al.
HEALTH AFFAIRS (2012)
Patients Value Metastatic Cancer Therapy More Highly Than Is Typically Shown Through Traditional Estimates
Seth A. Seabury et al.
HEALTH AFFAIRS (2012)
Survey Results Show That Adults Are Willing To Pay Higher Insurance Premiums For Generous Coverage Of Specialty Drugs
John A. Romley et al.
HEALTH AFFAIRS (2012)
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology
Lowell E. Schnipper et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Trends in adherence to recommended cancer screening: the US population and working cancer survivors
Tainya C. Clarke et al.
FRONTIERS IN ONCOLOGY (2012)
Bending the Cost Curve in Cancer Care
Thomas J. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
An economic evaluation of the war on cancer
Darius N. Lakdawalla et al.
JOURNAL OF HEALTH ECONOMICS (2010)
Adequacy of Published Oncology Randomized Controlled Trials to Provide Therapeutic Details Needed for Clinical Application
Jennifer M. Duff et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the US Preventive Services Task Force
Evelyn P. Whitlock et al.
ANNALS OF INTERNAL MEDICINE (2008)
Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia
Shelby D. Reed et al.
PHARMACOECONOMICS (2008)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
Adjusting the value of a statistical life for age and cohort effects
Joseph E. Aldy et al.
REVIEW OF ECONOMICS AND STATISTICS (2008)
Benefit design and specialty drug use
Dana P. Goldman et al.
HEALTH AFFAIRS (2006)
Daily cost of an intensive care unit day: The contribution of mechanical ventilation
JF Dasta et al.
CRITICAL CARE MEDICINE (2005)
The impact of state policy on the costs of HIV infection
DP Goldman et al.
MEDICAL CARE RESEARCH AND REVIEW (2001)
Impact of HAART on causes of death of persons with late-stage AIDS
GR Sansone et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2000)
Share Paper
